enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
11.96
+0.50 (4.34%)
At close: Mar 9, 2026, 4:00 PM EDT
11.83
-0.13 (-1.06%)
After-hours: Mar 9, 2026, 4:10 PM EDT
enVVeno Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 1.54 | 1.75 | 3.62 | 4.56 | 54.73 | 9.33 | Upgrade
|
| Short-Term Investments | 29.41 | 41.4 | 42.79 | 34.49 | - | - | Upgrade
|
| Cash & Short-Term Investments | 30.95 | 43.15 | 46.41 | 39.04 | 54.73 | 9.33 | Upgrade
|
| Cash Growth | -36.02% | -7.02% | 18.87% | -28.66% | 486.29% | 614.07% | Upgrade
|
| Prepaid Expenses | 0.55 | 0.58 | 0.51 | 0.39 | 0.31 | 0.23 | Upgrade
|
| Total Current Assets | 31.5 | 43.73 | 46.92 | 39.44 | 55.04 | 9.57 | Upgrade
|
| Property, Plant & Equipment | 0.82 | 1.19 | 1.68 | 2.19 | 2.61 | 0.94 | Upgrade
|
| Other Long-Term Assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.05 | 0.03 | Upgrade
|
| Total Assets | 32.35 | 44.95 | 48.64 | 41.66 | 57.7 | 10.54 | Upgrade
|
| Accounts Payable | 0.63 | 1.01 | 0.43 | 0.65 | 0.56 | 1.39 | Upgrade
|
| Accrued Expenses | 1.49 | 0.73 | 0.61 | 0.57 | 0.73 | 0.98 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 0.31 | Upgrade
|
| Current Portion of Leases | 0.29 | 0.36 | 0.34 | 0.31 | 0.29 | 0.31 | Upgrade
|
| Other Current Liabilities | - | - | - | - | - | 0.19 | Upgrade
|
| Total Current Liabilities | 2.4 | 2.1 | 1.37 | 1.53 | 1.58 | 3.19 | Upgrade
|
| Long-Term Leases | 0.51 | 0.7 | 1.06 | 1.4 | 1.72 | 0.25 | Upgrade
|
| Total Liabilities | 2.91 | 2.8 | 2.44 | 2.93 | 3.3 | 3.44 | Upgrade
|
| Common Stock | - | - | - | - | - | 0 | Upgrade
|
| Additional Paid-In Capital | 197.04 | 194.01 | 176.24 | 145.25 | 136.26 | 72.42 | Upgrade
|
| Retained Earnings | -167.59 | -151.86 | -130.04 | -106.52 | -81.85 | -65.32 | Upgrade
|
| Total Common Equity | 29.45 | 42.16 | 46.2 | 38.73 | 54.4 | 7.1 | Upgrade
|
| Shareholders' Equity | 29.45 | 42.16 | 46.2 | 38.73 | 54.4 | 7.1 | Upgrade
|
| Total Liabilities & Equity | 32.35 | 44.95 | 48.64 | 41.66 | 57.7 | 10.54 | Upgrade
|
| Total Debt | 0.79 | 1.06 | 1.4 | 1.72 | 2.01 | 0.88 | Upgrade
|
| Net Cash (Debt) | 30.16 | 42.09 | 45.01 | 37.33 | 52.72 | 8.45 | Upgrade
|
| Net Cash Growth | -36.14% | -6.49% | 20.58% | -29.20% | 523.64% | 1776.16% | Upgrade
|
| Net Cash Per Share | 51.98 | 85.94 | 128.07 | 137.93 | 212.59 | 229.11 | Upgrade
|
| Filing Date Shares Outstanding | 0.58 | 0.5 | 0.38 | 0.27 | 0.27 | 0.24 | Upgrade
|
| Total Common Shares Outstanding | 0.58 | 0.5 | 0.38 | 0.27 | 0.27 | 0.07 | Upgrade
|
| Working Capital | 29.1 | 41.64 | 45.55 | 37.91 | 53.46 | 6.38 | Upgrade
|
| Book Value Per Share | 50.98 | 84.15 | 121.42 | 143.11 | 201.07 | 97.75 | Upgrade
|
| Tangible Book Value | 29.45 | 42.16 | 46.2 | 38.73 | 54.4 | 7.1 | Upgrade
|
| Tangible Book Value Per Share | 50.98 | 84.15 | 121.42 | 143.11 | 201.07 | 97.75 | Upgrade
|
| Machinery | - | 1.44 | 1.4 | 1.37 | 0.81 | 0.48 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 0.19 | 0.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.